AXL and cancer: When stimulated through its ligand, growth-arrest specific factor 6 (Gas6), Axl activates myriad intracellular signaling pathways that contribute to the cancer phenotype, including: epithelial-mesenchymal transition, survival, proliferation, angiogenesis, chemotherapy resistance, and immune suppression [9, 10] (Fig 1, right).